John C. Jacobs
President and CEO, Director · NOVAVAX INC
Individual
- 2026
- Mar 9, 2026
- 4
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John C. Jacobs's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John C. Jacobs?
John C. Jacobs is a corporate insider, tracked as President and CEO, Director of NOVAVAX INC (NVAX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John C. Jacobs last file a Form 4?
The most recent primary Form 4 on record is dated 9 March 2026, one of 4 filings going back to 2026.
